Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission
Go back to Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 4.25 -0.11 (2.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.36 | 52 Week High | $21.49 | |||
| Open | $4.35 | 52 Week Low | $15.75 | |||
| Day High | $4.42 | P/E | 4.83 | |||
| Day Low | $4.11 | EPS | $0.88 | |||
| Volume | 252,335 | |||||

